Compare NATR & NRC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | NATR | NRC |
|---|---|---|
| Founded | 1972 | 1981 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Commercial Physical & Biological Resarch |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 470.3M | 428.2M |
| IPO Year | 1995 | 1997 |
| Metric | NATR | NRC |
|---|---|---|
| Price | $26.80 | $12.61 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 3 | 0 |
| Target Price | ★ $21.33 | N/A |
| AVG Volume (30 Days) | ★ 131.7K | 119.0K |
| Earning Date | 01-01-0001 | 05-05-2026 |
| Dividend Yield | N/A | ★ 5.12% |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 0.83 | 0.43 |
| Revenue | ★ $454,364,000.00 | $119,686,000.00 |
| Revenue This Year | $7.30 | N/A |
| Revenue Next Year | $3.44 | N/A |
| P/E Ratio | $32.63 | ★ $29.21 |
| Revenue Growth | ★ 2.03 | 1.81 |
| 52 Week Low | $11.01 | $9.76 |
| 52 Week High | $27.46 | $22.79 |
| Indicator | NATR | NRC |
|---|---|---|
| Relative Strength Index (RSI) | 69.22 | 32.77 |
| Support Level | $13.69 | $11.59 |
| Resistance Level | N/A | $16.63 |
| Average True Range (ATR) | 0.82 | 1.13 |
| MACD | -0.02 | -0.24 |
| Stochastic Oscillator | 90.46 | 12.96 |
Natures Sunshine Products Inc is a natural health and wellness company, predominantly engaged in the manufacturing and selling of nutritional and personal care products. It offers products related to Weight management, General health, Cardiovascular, Digestive, Immune, and Personal care. The company operates in four segments namely, Asia which is also its key revenue generating market, Europe, North America, Latin America, and Other.
National Research Corp is a provider of analytics and insights that facilitate measurement and improvement of the patient and employee experience while also increasing patient engagement and customer loyalty for healthcare providers, payers, and other healthcare organizations. Its portfolio of solutions represents a set of capabilities that individually and collectively provide value to clients. It operates in the United States and Canada, of which key revenue is derived from the United States.